Emergent Health Corp. (EMGE) Addresses Suspension

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Emergent Health Corp. (Other OTC: EMGE) Emergent would like to inform its shareholders that the Securities & Exchange Commission (SEC) ordered a trading suspension of its stock on the OTC Pink Sheets. The company is working to clarify the questions that have arisen regarding the company’s issuance of stock and trading in the company’s stock, including clarifying the accuracy and adequacy of the publicly disseminated information related to Emergent. The order of suspension is for the period from 9:30 AM EDT on September 30, 2009 through 11:59 PM EDT on October 13, 2009.

The company recently appointed Richard S. Lane, Esq., an attorney experienced in working with the SEC, to its Board of Directors to assist in Corporate Compliance. Under review are plans, including a Form 10 or S-1 filing as well as Board member and Advisory Board member expansion.

About Emergent Health Corp.

Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. Using patented and patent pending nutritionally designed products, Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine as defined by the National Institute of Health.

Sign up for Free Newsletter Updates here: http://emergenthealth.com

We believe our long-term prospects remain positive as evidenced by our recently posted Balance Sheet located at the Pink Sheets Information filings.

This press release contains certain "forward-looking" statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the company.

This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.

Emergent Health Corp.
Investor Relations, 866-427-6143